CCI vs OGEN · P/E 40, rev $6.57B vs rev $37.7K
Crown Castle (CCI) versus Oragenics Inc (OGEN) — a side-by-side from cached financials, not a winner call.
Crown Castle (CCI) is a reit - specialty company listed on US.
Oragenics Inc (OGEN) is a biotechnology company listed on US.
Latest reported CCI revenue for 2024-12-31 was $6.57B. Net income was -$3.90B. Revenue was down 5.9% from 2023-12-31 to 2024-12-31. CCI currently screens at market cap $40.93B and trailing P/E 39.6.
Latest reported OGEN revenue for 2023-12-31 was $37.7K. Net income was -$20.7M. Revenue was down 71.4% from 2022-12-31 to 2023-12-31. OGEN currently screens at market cap $2.7M.
CCI currently screens at market cap $40.93B and trailing P/E 39.6. OGEN currently screens at market cap $2.7M.
Not investment advice. Open the CCI and OGEN stock pages for the full models.
Not investment advice.